Resources

Main Content

Newsletter Summer 2022

Mississippi Cancer Registry

June 2022

Volume 17 Issue 2

2022 MCR Fall Educational Workshop
CONGRATS! | Upcoming Webinars
Educational Corner
MCR Staff
Abstracting Resources

Join us September 22, 2022 for the
MCR Fall Educational Workshop:
Putting the Pieces together

Main Speaker will be Denise Harrison, BS, CTR, and Education Director for NCRA.
UMMC Conference Center at the Jackson Medical Mall 350 W. Woodrow Wilson Drive, Jackson, MS 39213

This one day event will provide an educational forum for healthcare professionals to broaden their knowledge with the cancer registry. The registration fee is $20. Breakfast and lunch will be provided.
Continuing Education Hours will be awarded upon the approval from NCRA. This event is co-sponsored by the

Mississippi Cancer Registrars Association.
Contact: Angel Davis, RHIT, CTR
601-815-5481
adavis6@umc.edu

Educational Corner:
Are you coding correctly?SSDI’S - LUNG……
Visceral and Parietal Pleural Invasion
CodeDescription
0

No evidence of visceral pleural invasion identified

Tumor does not completely traverse the elastic layer of the pleura

Stated as PL0

4

Invasion of visceral pleura present, NOS

Stated as PL1 or PL2

5

Tumor invades into ot through the parietal pleura OR chest wall

Stated as PL3

6Tumor extends to pleura, NOS; not stated if visceral or parietal
8

Not applicable: Information not collected for this case

(IF this item is required by your standard setter, use of code 8 will result in an edit error.

9

Not documented in medical record

No surgical resection of primary site is performed

Visceral Pleural Invasion not assessed or unknown if assessed or cannot be determined


*** Must have tissue from resection to code this item*


NOTES:
Physician statement of Visceral and Parietal Pleural Invasion can be used to code this data item when no other information is available.
Code 0 for in situ (behavior/2) tumors.
A surgical resection must be done to determine if the visceral and/or parietal pleural are involved.
Do not use imaging findings to code this data item.
Code 9 when…
*A FNA only is performed – FNA is not adequate to assess pleural layer invasion.
*Surgical resection of the primary site is performed and there is no mention of visceral and/or parietal pleural invasion.

*Source – SSDI Manual

EOD – Colon….. Peritonealized vs Non-Peritonealized

Code 300 Invasion through wall, NOS
Invasion through muscularis propria or muscularis, NOS
Non-peritonealized pericolic/perirectal tissues invaded (see Code 400)
Pericolic/perirectal tissues invaded, NOS (See Note 5)
Perimuscular tissue invaded
Subserosal tissue/ (sub) serosal fat invaded
Transmural, NOS
Wall, NOS


Code 400 Adjacent (connective) tissue(s), NOS
Fat, NOS
Gastrocolic ligament (transverse colon and flexures)
Greater omentum (transverse colon and flexures)
Mesentery (including mesenteric fat, mesocolon)
Pericolic fat
Perirectal fat

Peritonealized pericolic/perirectal tissues invaded (see Code 300 for non-peritonealized pericolic/perirectal tissues invaded. See Note 5)

Rectovaginal septum (rectum)

Retroperitoneal fat (ascending & descending colon only)


EOD Primary Tumor – Note 5

Note 5: Invasion into "pericolonic/pericolorectal tissue" can be either codes 300 or 400, depending on the primary site. Some sites are enitrely peritonealized; some sites are only partially peritonealized or have no peritoneum. Code 300 may not be used for sites that are entirely pertonealized (cecum, transverse colon, sigmoid colon, rectosigmoid colon, upper third rectum).

  • Code 300
    • Invasion through muscularis propria or muscularis, NOS
    • Non-peritonealized pericolic/perirectal tissues invaded [Ascending Colon/Descending Colon/Hepatic Flexure/Splenic Flexure/Upper two thirds of rectum: Posterior surface; Lower third of rectum]
    • Subserosal tissue/(sub) serosal fat invaded
  • Code 400
    • Mesentery
    • Peritonealized pericolic/perirectal tissues invaded [Ascending Colon/Descending Colon/Hepatic Flexure/Splenic Flexure/Upper two thirds of rectum: anterior and lateral surfaces; Sigmoid Colon; Transverse Colon; Rectosigmoid; REctum; middle third anterior surface]
    • Pericolic/Perirectal fat

      • If the pathologist does not further describe the pericolic/perirectal tissues: as either"non-peritonealized pericolic/perirectal tissues" vs "peritonealized pericolic/perirectal tissues" and the gross description does not describe the tumor relation to the serosa/peritoneal surface, and it cannot be determined whether the tumor arises in a peritonealized portion of the colon, code 300.

Source EOD Manual; NAACCR Webinar Colon 2022

Abstracting Resources

AJCC Cancer Staging Manual

Cases with a diagnosis date of 01/01/2018 and forward should be staged using AJCC 8th Edition Cancer Staging Manual. The 3rd printing 2018 Edition is now available.

Please visit https://www.facs.org/quality-programs/cancer-programs/american-joint-committee-on-cancer/ for all 8th Edition updates and corrections. For all other information, visit https://www.facs.org/quality-programs/cancer-programs/american-joint-committee-on-cancer/.

Summary Stage 2018

The 2018 version of Summary Stage applies to every site and/or histology combination, including lymphomas and leukemias. Summary Stage uses all information available in the medical record; in other words, it is a combination of the most precise clinical and pathological documentation of the extent of disease. The Summary Stage 2018 manual is available at https://seer.cancer.gov/tools/ssm/.

Site Specific Data Items (SSDI)

Site Specific Data Items (SSDI) are similar to the Site Specific Factors (SSF) collected with Collaborative Stage. These data items are specific to certain site/histology combinations. For example, the SSDI’s for breast will be used to collect information such as estrogen receptor status, progesterone receptor status, Her2 status, Nottingham grade, and additional information related to primary tumors of the breast. The information collected in these data items are specific to breast. The SSDI manual is available at https://apps.naaccr.org/ssdi/list/.

Grade

Beginning with cases diagnosed in 2018 grade information will be collected in three fields: Clinical Grade, Pathological Grade, and Post-Therapy Grade. Within the Grade Manual you will find definitions for the three new grade data items, coding instructions, and the site/histology specific grade tables. The Grade manual is available at https://www.naaccr.org/SSDI/Grade-Manual.pdf?v=1527859766.

SEER Hematopoietic and Lymphoid Neoplasm Database

This provides data collection rules for hematopoietic and lymphoid neoplasms for 2010+. The SEER Hematopoietic and Lymphoid Neoplasm manual is available at https://seer.cancer.gov/tools/heme/ Hematopoietic_Instructions_and_Rules.pdf.

Solid Tumor Coding Manual

Use the 2018 Solid Tumor coding rules to determine the number of primaries to abstract and the histology to code for cases diagnosed 2018 and forward. The Solid Tumor coding rules replace the 2007 Multiple Primary and Histology (MP/H) Rules. The manual is available at https://seer.cancer.gov/tools/solidtumor/. The change log contains updates made to the FINAL module sections. This does not include changes made to the drafts.

STORE Manual

The STORE Manual has replaced the FORDS Manual. The STORE is now available at https://www.facs.org/quality-programs/cancer-programs/national-cancer-database/ncdb-call-for-data/registry-manuals/.

 

MCR STAFF

Director UMMC & MCR: Deirdre Rogers, dbrogers@umc.edu

MCR Manager: Angel Davis, adavis6@umc.edu

Clinical Systems Analyst-Intermediate: Tresheena Boyd, tboyd@umc.edu

Data Quality Analyst–Trainer: Lisa Hamel, lhamel@umc.edu

Data Quality Analyst-Auditor: April Wright, ahuggins@umc.edu

 

Cancer Registrars:

Stacy Major, semajor@umc.edu

Laken A. Frederick, lfrederick@umc.edu

Madeline N. Hall, mnhall@umc.edu

Mallory R. Israel, misrael@umc.edu

 

Administrative Assistant:

Michelle Smith, mrsmith2@umc.edu

 

University of MS Medical Center

2500 North State Street

Jackson, MS 39216

Phone: 601-815-5482

Fax: 601-815-5483